Pregunta:
It defines the stability data package for a new drug substance or drug product that is sufficient for a registration application within the three regions of the EC, Japan, and the United States.
Autor: LEIGHTON DWIGHT OBILLOSRespuesta:
Objectives of the Guideline
0 / 5 (0 calificaciones)
1 answer(s) in total
